S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
AI Stock Caught Trading Under Secret Name (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Better Than Oil Stocks (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
AI Stock Caught Trading Under Secret Name (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Better Than Oil Stocks (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
AI Stock Caught Trading Under Secret Name (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Better Than Oil Stocks (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
AI Stock Caught Trading Under Secret Name (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Better Than Oil Stocks (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
NASDAQ:SGRY

Surgery Partners (SGRY) Stock Price, News & Analysis

$32.86
-0.03 (-0.09%)
(As of 02/22/2024 ET)
Today's Range
$32.51
$33.35
50-Day Range
$30.37
$35.07
52-Week Range
$22.05
$45.79
Volume
839,417 shs
Average Volume
848,942 shs
Market Capitalization
$4.16 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.13

Surgery Partners MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
37.3% Upside
$45.13 Price Target
Short Interest
Bearish
9.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.62mentions of Surgery Partners in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$267.93 M Sold Last Quarter
Proj. Earnings Growth
10.96%
From $0.73 to $0.81 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.05 out of 5 stars

Medical Sector

697th out of 934 stocks

General Medical & Surgical Hospitals Industry

5th out of 5 stocks


SGRY stock logo

About Surgery Partners Stock (NASDAQ:SGRY)

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. The company was founded in 2004 and is headquartered in Brentwood, Tennessee.

SGRY Stock Price History

SGRY Stock News Headlines

Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
Surgery Partners (SGRY) Set to Announce Earnings on Monday
Surgery Partners, Inc. (NASDAQ:SGRY) Short Interest Update
Surgery Partners, Inc. (NASDAQ:SGRY) CEO Sells $202,762.40 in Stock
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
Surgery Partners Inc (SGRY)
HCA Healthcare lifts peers after Q4 beat
Surgery Partners (SGRY) Receives a Buy from RBC Capital
Is Surgery Partners (SGRY) a Good Long-Term Stock?
Surgery Partners Backs Annual Revenue Guidance In Line With Estimates
Surgery Partners, Inc.'s (NASDAQ:SGRY) Profit Outlook
Surgery Partners, Inc. Completes Refinancing Transaction
See More Headlines
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2021
Today
2/22/2024
Next Earnings (Confirmed)
2/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
N/A
Current Symbol
NASDAQ:SGRY
Employees
12,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$45.13
High Stock Price Target
$51.00
Low Stock Price Target
$35.00
Potential Upside/Downside
+37.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$-54,600,000.00
Pretax Margin
4.25%

Debt

Sales & Book Value

Annual Sales
$2.54 billion
Cash Flow
$0.86 per share
Book Value
$23.35 per share

Miscellaneous

Free Float
123,204,000
Market Cap
$4.16 billion
Optionable
Optionable
Beta
2.74
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report














SGRY Stock Analysis - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SGRY shares.
View SGRY analyst ratings
or view top-rated stocks.

What is Surgery Partners' stock price target for 2024?

7 brokerages have issued 12 month target prices for Surgery Partners' stock. Their SGRY share price targets range from $35.00 to $51.00. On average, they predict the company's share price to reach $45.13 in the next year. This suggests a possible upside of 37.3% from the stock's current price.
View analysts price targets for SGRY
or view top-rated stocks among Wall Street analysts.

How have SGRY shares performed in 2024?

Surgery Partners' stock was trading at $31.99 on January 1st, 2024. Since then, SGRY stock has increased by 2.7% and is now trading at $32.86.
View the best growth stocks for 2024 here
.

Are investors shorting Surgery Partners?

Surgery Partners saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 7,780,000 shares, an increase of 9.4% from the January 15th total of 7,110,000 shares. Based on an average trading volume of 988,900 shares, the days-to-cover ratio is currently 7.9 days. Approximately 9.5% of the company's stock are sold short.
View Surgery Partners' Short Interest
.

When is Surgery Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024.
View our SGRY earnings forecast
.

How can I listen to Surgery Partners' earnings call?

Surgery Partners will be holding an earnings conference call on Monday, February 26th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13744429".

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings results on Tuesday, November, 2nd. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.04. The company had revenue of $559.20 million for the quarter, compared to the consensus estimate of $554.15 million. Surgery Partners had a positive trailing twelve-month return on equity of 2.70% and a negative net margin of 1.26%. During the same quarter in the prior year, the company earned ($0.59) EPS.

What ETFs hold Surgery Partners' stock?

ETFs with the largest weight of Surgery Partners (NASDAQ:SGRY) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS) and BlackRock Future Innovators ETF (BFTR).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners updated its FY 2023 earnings guidance on Monday, January, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.8 billion-$2.8 billion, compared to the consensus revenue estimate of $2.8 billion.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Surgery Partners own?
Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a number of institutional and retail investors. Top institutional investors include Bain Capital Investors LLC (39.49%), Vanguard Group Inc. (5.86%), Clearbridge Investments LLC (4.37%), Dimensional Fund Advisors LP (1.45%), Avidity Partners Management LP (0.92%) and Price T Rowe Associates Inc. MD (0.88%). Insiders that own company stock include Andrew T Kaplan, Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Harrison R Bane, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends
.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SGRY) was last updated on 2/23/2024 by MarketBeat.com Staff